Figure 7.
ERKSEM mice have fewer exhausted LCMV-specific CD8+ T cells and lower virus titers in the chronic phase of LCMV CL 13 infection. (A) The proportion (blood and spleen) and absolute number of CD8+Tetramer+ (GP33+ or GP276+) cells and the fraction of (B) KLRG1+, PD-1+, TIM3+, 2B4+, LAG3+, TIGIT+ or (C) PD-1+KLRG1−, Eomes+, PD-1 KLRG1+Eomes+ cells of CD8+Tetramer+ cells were quantified in the spleen of WT and ERKSEM mice on Day 35 post LCMV CL13 infection. (D) The fraction of CD8+ T cells expressing IFNγ or CD107a was quantified in spleen cells isolated from WT and ERKSEM mice on Day 35 post LCMV CL13 infection and restimulated with GP33 peptide or PMA and ionomycin (PI). (E) Virus titers in kidney of WT and ERKSEM mice on Day 35 post LCMV CL13 infection. Data from N=12 mice/group pooled from 3 independent experiments are shown. N.S. = not significant, *p<0.05, **P<0.01, ***p<0.001, ****p<0.0001 by Student t-test.